Just Because You Can Doesn’t Mean You Should: Gene Therapy is Not the Solution to Every Problem

Please subscribe and tell your friends why it’s worthwhile. Quality journalism costs money. When you subscribe to Timmerman Report at $149 per year, you reward quality independent biotech reporting, and encourage more.


You may also like

Don’t Pull Back on Basic Biology for Psychiatry: It’s Time to Double Down
Dr. Jekyll and Mr. Pharma-Bro: Coping With My Split Personality
Investing from the Heart to Find New ALS Therapies
The Biotech Industry Can Help Address the Opioid Crisis. But We Aren’t Doing Enough